We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Value of Common Knee Surgery Challenged

By HospiMedica staff writers
Posted on 01 Aug 2002
A study has shown that osteoarthritis patients who underwent a mock surgery, or placebo, were as likely to report pain relief as patients who had arthroscopic knee surgery. More...
The study appeared in the July 11, 2002, issue of The New England Journal of Medicine.

Investigators randomized 180 patients with knee pain into three groups. One group received debridement, in which worn, torn, or loose cartilage was cut way and removed. The second group underwent arthroscopic lavage, in which the bad cartilage was flushed out. The third group underwent simulated arthroscopic surgery, in which small incisions were made but no instruments were inserted and no cartilage removed.

During three years of follow-up, patients in all three groups reported improvements in pain and ability to function. Neither of the intervention groups reported less pain or better function than the placebo group. In fact, placebo patients reported better outcomes than the debridement patients at certain times. Throughout the two years, the patients were unaware of which treatment they received. These results, say the investigators, raise questions about what really causes the improvements seen with lavage or debridement and suggest the same benefits may be achieved through placebo surgery.

The study was conducted by researchers at the Houston Veterans Affairs Medical Center and Baylor College of Medicine (Houston, USA). "The fact that the effectiveness of arthroscopic lavage or debridement in patients with osteoarthritis of the knee is not greater than that of placebo surgery makes us question whether the one billion plus dollars spent on these procedures might not be put to better use,” said Dr. Nelda P. Wray, lead investigator and a health services researcher.




Related Links:
Baylor

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.